- Medical - Distribution
- Healthcare
-
2.27
EPS
-
43.55
P/E
-
24.1B
MARKET CAP
-
2.03%
DIV YIELD
Company Overview
7000 CARDINAL PLACE,DUBLIN OH 43017,6147573033
CEO
Mr. Jason M. Hollar
Employess
47040
Sector
Healthcare
Industry
Medical - Distribution
Website
https://www.cardinalhealth.com
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Next Earnings Date
Nov. 1, 2024
Ex Dividends date
Jul. 15, 2024
Dividend Date
July 1, 2024
YTD Performance
-3.61%
Fiscal Year End
06-30
IPO Date
1983-08-04
Growth Rates
| (avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
|---|---|---|---|---|
| Sales/Revenue | 7.33% | 8.43% | 10.26% | 13.04% |
| EPS | 0.20% | 4.05% | 27.64% | 129.94% |
| Equity | -3.98% | -8.02% | -37.35% | -303.82% |
| Cash | 7.84% | 18.06% | 13.42% | -14.29% |
| Return On Capital (ROIC) | 17.76% | 26.87% | 34.30% | 16.14% |
Debt
| year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Short Term Debt | 792 | 580 | 871 | 10 | 452 |
| Long Term Debt | 3,910 | 4,740 | 5,360 | 6,760 | 7,580 |
| LT Finance Leases | 3,910 | 4,740 | 5,360 | 6,760 | 7,580 |
| Shares Outstanding | 261 | 279 | 292 | 293 | 300 |
| Market Cap | 24,700 | 14,600 | 16,700 | 15,300 | 14,300 |
Price
News
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
1 monthCardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know
1 monthCardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.
zacks.com
Dividend Income: Lanny's July 2024 Summary
1 monthIn July, we (my wife and I) received a dividend income total of $2,836.82. 2023 was up 24%. 7 months down in 2024 and the S&P 500 is still up almost 13%, despite the recent sell-offs. We have a high likelihood of a rate cut in September, but too much speculation is happening beyond that date. Time is ticking on that FOMC meeting.
seekingalpha.com
Cardinal Health: Growth Headwinds Ahead
2 monthsCardinal Health's recent dividend raise (about 1%) reflects growth pressure ahead. With a ~13x P/E, valuation seems reasonable on the surface. However, when adjusted for growth, the current valuation points to an unfavorable return profile.
seekingalpha.com
Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know
2 monthsCardinal Health (CAH) reachead $100.83 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
zacks.com
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
2 monthsWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com
Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts
2 monthsIn the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.
zacks.com
Why the Market Dipped But Cardinal Health (CAH) Gained Today
2 monthsIn the closing of the recent trading day, Cardinal Health (CAH) stood at $95.84, denoting a +0.44% change from the preceding trading day.
zacks.com
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
2 monthsFDA investigations into Cardinal Health's (CAH) China-based syringe manufacturers, Jiangsu Shenli and Jiangsu Caina, reveal significant quality violations, prompting recalls and import alerts.
zacks.com
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
2 monthsDUBLIN, Ohio , July 23, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
prnewswire.com
Why the Market Dipped But Cardinal Health (CAH) Gained Today
2 monthsCardinal Health (CAH) closed at $95.97 in the latest trading session, marking a +0.59% move from the prior day.
zacks.com
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
2 monthsCardinal Health (CAH) concluded the recent trading session at $93.74, signifying a -0.38% move from its prior day's close.
zacks.com